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Symptoms of endometriosis (ENDO), among others, include pelvic/abdominal and muscle
pain. Non-steroidal anti-inflammatory agents are first-line treatment for this pain. Similar
to women, rats with surgically induced ENDO, but not its surgical control, exhibit vaginal
hyperalgesia, which in rats is evidenced by a decreased threshold for the visceromotor
response (VMR) induced by vaginal distention. Here we assess the VMR in rats with
implanted probes that telemetrically transmit EMG activity from the abdominal muscle.
The feasibility and sensitivity of this technique for monitoring the VMR threshold across
the estrous cycle and the influence of Indomethacin on ENDO-induced vaginal hyperalgesia
were evaluated. VMR thresholds in response to vaginal distention with an infusion pump
were measured in different estrous stages. Indomethacin (5 or 10 mg/kg i.p. or s.c.) was
injected in proestrus rats and 40–60 min later the VMR threshold was measured.The VMR
threshold varied across the estrous cycle only in ENDO rats, being lowest in proestrus.
Indomethacin increased this threshold in proestrus ENDO rats. These results show that
telemetric assessment of the VMR is a sensitive tool, suitable for long-term studies in
conscious rats.The results with this technique also suggest that ENDO-associated vaginal
hyperalgesia involves COX activity, the feature that also underlies inflammatory pains.
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INTRODUCTION
Endometriosis (ENDO) is an estrogen-dependent condition
defined by the presence of growths of endometrial tissue outside
the uterus. ENDO is also considered an inflammatory condition
because immune cells and numerous inflammatory mediators
including prostaglandins, cytokines, chemokines, and growth fac-
tors are involved in its development and maintenance (Bulun et al.,
2005; Maybin et al., 2011; Stratton and Berkley, 2011). Among
these inflammatory molecules, PGE2 and COX2 appear to play key
roles because PGE2 stimulates aromatase activity in endometrial
stromal and epithelial cells and thereby promotes local estro-
gen production that is essential for growth and maintenance of
endometrial implants, and COX2 maintains high levels of PGE2
synthesis in ectopic endometrial foci and eutopic endometrium in
women with ENDO and itself is subject to regulation by PGE2 and
other inflammatory mediators (Noble et al., 1997; Ota et al., 2001;
Chishima et al., 2002; Bulun et al., 2005; Banu et al.,2008). In accor-
dance, COX2 inhibitors are effective in reducing ectopic implant
growth and improving fertility in murine models when animals
are treated in the early stages of ENDO development (Golan et al.,
1986; Dogan et al., 2004; Efstathiou et al., 2005; MacHado et al.,
2010).
Women with ENDO often experience severe pelvic pain. Non-
steroidal anti-inflammatory drugs (NSAIDs) are the first-line
treatment for pelvic/abdominal pain but their use is limited
because of side effects (Stratton and Berkley, 2011). Surgical
removal of lesions often fails to alleviate pain long-term, and
hormonal treatments that decrease estrogen levels, although effec-
tive for the pain, often have intolerable side effects and are
unsafe for long-term use. Therefore, new and long-term treat-
ment options with reduced side effects and efficacy in ENDO are
urgently needed.
In an established rat model of ENDO, pieces of uterine tis-
sue are implanted in the abdominal cavity (Vernon and Wilson,
1985). The transplants form cysts that grow rapidly during the
first month, continue growing in the following months to reach
full size by 8–10 weeks (Vernon and Wilson, 1985). Similar to
women, cysts in rats attract their own nerve and blood supply
(Zhang et al., 2008; McAllister et al., 2012). Another resemblance
to women’s signs is significantly elevated levels of inflammatory
mediators (Bergqvist et al., 2001; Anaf et al., 2002; Zhang et al.,
2008; MacHado et al., 2010). Importantly like women, rats with
ENDO exhibit abnormal sensory signaling associated with the
pelvic area, such as vaginal hyperalgesia (dyspareunia in women;
Cason et al., 2003) and referred abdominal muscle hyperalgesia
(Nagabukuro and Berkley, 2007).
In the previous studies, vaginal hyperalgesia in rats has been
assessed either with a behavioral psychophysical test (Cason et al.,
2003), or with a technique that measures abdominal muscle elec-
trical activity in response to vaginal distention (Nagabukuro and
Berkley, 2007). This later measure, which is a referred abdom-
inal muscle response to noxious stimuli, is called visceromo-
tor response (VMR). Although these techniques are sensitive
and have been successfully used to reveal estrous differences in
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pelvic nociception and effects of drugs and surgical manipula-
tions (Cason et al., 2003; Berkley et al., 2007; Nagabukuro and
Berkley, 2007; Dmitrieva et al., 2010), they are labor-intensive and
cumbersome to use for drug testing. Here we developed a new
technique that combined VMR with vaginal distention and tele-
metric methodology. We then validated its applicability in two
experimental settings. In the first study, we tested changes in
ENDO-induced vaginal hyperalgesia across the estrous cycle. In
the second study, we tested the hypothesis that COX is involved in
pathology of ENDO-associated vaginal hyperalgesia by studying
the effect of a non-selective COX inhibitor Indomethacin on the
VMR threshold as a proxy of vaginal hyperalgesia.
MATERIALS AND METHODS
This study was approved by the Florida State University’s Animal
Care and Use Committee, Protocol #0927. The care and use of
animals conformed to the recommendations in the Guide for the
Care and Use of Laboratory Animals (PHS/NIH) and the Animal
Welfare Act (USDA).
SUBJECTS
Sprague-Dawley female rats were used. Estrous cycle was deter-
mined daily by cytological examination of vaginal lavage collected
approximately 2 h after lights on (Becker et al., 2005).
Endometriosis and shamENDO surgeries were performed under
ketamine/xylazine anesthesia (K/X: 73/8.8 mg/kg i.p.) following
aseptic precautions. During surgery and the recovery period,
the rat was kept warm on a heating pad. A small incision
was made in the middle of the abdomen. A small, approxi-
mately 1 cm segment of the middle part of one uterine horn
was clamped between two hemostats and excised. The cecum
and adjacent intestines were exposed. Four 2 mm× 2 mm biop-
sies of the excised uterine tissue, or fat in shamENDO rats,
were sutured on alternate mesenteric cascade arteries. Muscle
and skin were sutured separately. Bupivacaine was given locally
and butorphanol, s.c immediately after surgery to alleviate post-
operative pain. Rats were monitored on a daily basis for any sign
of distress.
TELEMETRIC PROBE IMPLANTATION
Seven weeks after ENDO/shamENDO surgery, under aseptic con-
ditions and K/X anesthesia, a telemetric probe (TA11CTAF40,
DSI, St. Paul, MN, USA) was implanted under the skin of the
right abdominal flank. Electrodes were tunneled under the skin
and implanted in the left inguinal muscle. The skin was sutured.
Recovery proceeded as described above. On rare occasions, some
rats developed a seroma that was managed by aspiration of clear
fluid from the pocket around the probe (under halothane gas anes-
thesia). This seroma usually subsided in a few days. Rats did not
exhibit stress behavior related to the implant. Experiments began
at least 7 days after implantation. All rats were habituated to the
restraining box and the experimental setting during three to four
training sections before VMR recording and did not show any sign
of discomfort.
Visceromotor response to vaginal distention in conscious rats
was assessed with the Ponemah Telemetry System (DSI, St. Paul,
MN, USA), which consisted of a receiver, data exchange matrix,
acquisition interface, and a computer with a synchronization
board (Figure 1A). The rat was placed in a transparent plexiglass
box that gently, but not aversively, restrained it. The restrain-
ing box was placed on the receiver. A small balloon (∼10 mm
diameter when fully inflated) connected to a pressure transducer
was inserted into the middle of the vaginal canal. After ∼10 min
of resting period, the balloon was inflated by an infusion pump
(0.3 ml/min, 1 ml maximum). Electrical activity from the abdom-
inal muscle (electromyography, EMG) was relayed to the DSI
system and synchronized with the amplified and digitalized signal
from the pressure transducer. EMG activity was recorded during
∼5 min before and during the time when the vaginal balloon was
inflated.
The integral of the rectified EMG signal was calculated in
100 ms intervals by the analysis module of the Ponemah System.
The volume threshold that corresponded to VMR (Figure 1B)
200% or higher than baseline activity was calculated as reported
previously (Nagabukuro and Berkley, 2007). VMR thresholds were
obtained 1–2 days between the sessions, two to four baselines per
each estrous stage (metestrus DI, diestrus DII, proestrus P, and
estrus E,) and then averaged for each stage for each rat.
Indomethacin was dissolved in a mixture of DMSO: cremophor:
saline (1:1:8). One of two doses (5 mg/kg, i.p. only or 10 mg/kg)
or vehicle was injected i.p. or s.c. in the neck area when the rat was
in proestrus. The VMR threshold was assessed 40–60 min later.
STATISTICAL ANALYSIS
Differences between VMR thresholds in different estrous stages
were analyzed by ANOVA followed by Tukey post hoc tests.
Differences in VMR thresholds between baseline, vehicle, and
Indomethacin groups were analyzed by ANOVA followed by
Dunnett or t -test as appropriate. Differences with p< 0.05 were
considered significant.
RESULTS
ESTROUS CYCLE DIFFERENCES
Baseline data were obtained from rats (n= 20) in different estrous
stages for 3–5 weeks beginning a minimum of 8 weeks after
ENDO/sham ENDO surgery when the cyst innervation and vagi-
nal hyperalgesia are fully developed (McAllister et al., 2012). The
VMR thresholds were assessed two to four times for each estrous
stage for each rat; the individual values remained consistent dur-
ing the entire study. Average baseline VMR thresholds for each
stage are presented for ENDO and shamENDO groups separately
in Figure 2.
Statistical analysis showed that VMR thresholds in ENDO
rats were significantly different from thresholds measured in
shamENDO rats (p< 0.001). In agreement with our earlier
published data obtained using the VMR technique in lightly
anesthetized or tethered rats (Nagabukuro and Berkley, 2007;
Dmitrieva et al., 2010), the VMR thresholds varied across the
estrous cycle in ENDO rats, with the threshold being lowest in
proestrus (p< 0.005). On average, the VMR threshold in ENDO
rats in the present study in proestrus were 15–19% lower than
the thresholds observed in other stages. Again, similar to previ-
ous observations, the VMR threshold in proestrus ENDO rats was
on average 42.4% lower than that in shamENDO rats. Finally,
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FIGURE 1 | (A) Experimental setting for recording of the visceromotor
response (VMR) to vaginal stimulation with the Ponemah Telemetric
System (DSI, St. Paul, MN, USA). Pressure in the vaginal balloon was
generated by an infusion pump. The EMG signal from the electrode
implanted in the abdominal muscle was converted into radio signals by the
telemetric probe and transmitted to a receiver connected to the
acquisition module of the Ponemah System and synchronized with the
incoming signal from the pressure transducer. (B) A recording of EMG
activity during vaginal distension before and after 10 mg/kg Indomethacin
(i.p.) injection in the same rat. The first arrow shows the beginning of
vaginal distention, and the second arrow shows the VMR threshold. The
VMR threshold increased after Indomethacin.
the threshold in shamENDO rats did not exhibit estrous cycle
differences (p= 0.752).
Indomethacin was injected first i.p. (5 or 10 mg/kg) in
proestrus ENDO and shamENDO rats (n= 9). Neither dose
of Indomethacin significantly changed the VMR threshold in
shamENDO rats. In contrast, the same doses significantly
increased the thresholds in ENDO rats in a dose-dependent man-
ner (Figures 1B and 3). The dose 10 mg/kg produced a significant
increase in VMR threshold of 81± 14.6% compared with both
baseline and the effect produced by vehicle (p< 0.05).
This increase produced by Indomethacin was transient: the
threshold measured 4 days later, when the rat was in proestrus,
was comparable to baseline values before the treatment (data
not shown). Although the vehicle injected i.p. produced a
small increase (∼28%, Figure 3), this effect was not signifi-
cantly different from baseline (p= 0.132). To verify whether the
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FIGURE 2 | Estrous variations inVMR to vaginal distention
(Volume threshold) in rats >8weeks after ENDO or shamENDO
surgery. Baseline thresholds were measured across the estrous
cycle over 3–5 weeks and then averaged for each estrous stage (i.e.,
in metestrus DI, diestrus DII, proestrus P, and estrus E). ANOVA
showed that thresholds in ENDO rats were significantly different than
thresholds in shamENDO rats (p<0.001). *p<0.005; **p<0.001,
compared to P.
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FIGURE 3 | Effects of i.p. injection of two doses of Indomethacin and
vehicle on theVMR threshold in rats after ENDO or Sham ENDO
surgery. Although vehicle produced a small increase in the VMR threshold,
this increase was not significantly different from baseline. The increase
produced by 10 mg/kg of Indomethacin was significantly higher than the
increase produced by vehicle. *p<0.05 compared to vehicle.
vehicle-induced effect was due to the i.p. injection or the vehi-
cle itself, we injected the vehicle and one dose of Indomethacin
(10 mg/kg) s.c. in the neck region in a separate group of ENDO rats
(n= 4, Figure 4). In these rats, Indomethacin but not the vehicle
produced a significant increase (p< 0.05, 93.5± 36%). Therefore,
it was the i.p. injection, not the vehicle, that produced the observed
increase in the absence of the drug.
DISCUSSION
Using a telemetric data acquisition technique we were able to carry
out a long-term study in conscious rats that, first, involved collect-
ing baseline measures of VMR thresholds across the estrous cycle
over 3–5 week period, and then, studying the effect of one or two
doses of Indomethacin on the VMR threshold.
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FIGURE 4 | Effect of 10mg/kg of Indomethacin injected s.c. in the neck
on theVMR threshold. *p<0.05 compared to vehicle.
The first set of findings confirmed our previously published
results on estrous cycle differences in the VMR threshold obtained
with a non-telemetered system (Nagabukuro and Berkley, 2007).
Similar to this earlier study, ENDO, but not its surgical con-
trol (shamENDO), significantly decreased the VMR threshold in
all stages of the estrous cycle, being lowest in proestrus (when
ovarian hormones plasma levels are highest). Therefore, we con-
firmed here that in cycling rats surgically induced ENDO pro-
duces vaginal hyperalgesia, the severity of which parallels estradiol
levels.
In the second set of experiments, we further validated the
technique by studying the effect of a NSAID Indomethacin on
the hyperalgesia: Indomethacin increased the VMR threshold in
ENDO rats when injected either i.p. or s.c. but did not affect this
threshold in the shamENDO group: i.e., Indomethacin alleviated
only ENDO-induced vaginal hyperalgesia. These findings imply
that COX plays a role in maintenance of ENDO-associated vaginal
hyperalgesia.
Some possible sites of Indomethacin action include (i) periph-
eral, locally active COX, whose enzymatic products, such as
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PGE2, may activate the visceral afferents that innervate the cysts,
(ii) COX located in the dorsal root ganglion, and (iii) cen-
tral sites in the spinal cord and/or brain. Previously, we have
shown that afferent fibers, whose branches supply the devel-
oped endometrial growths are overactive, which indicates that
they are sensitized (Berkley et al., 2004; McAllister et al., 2012).
It has been found in other conditions that afferent overactiv-
ity can be a result of sensory activation and sensitization by
COX2 products (Rendig et al., 1994; Su and Gebhart, 1998; Su
et al., 1999).These findings together support a peripheral effect
of Indomethacin in the present study. The presence of COX
enzymes in dorsal root ganglia and spinal cord, and inhibition
of inflammation-induced PGE2 in cerebrospinal fluid and hyper-
algesia by intraspinal COX2 inhibitors suggest that Indomethacin
could also suppress prostaglandin production centrally (Samad
et al., 2001; Yaksh et al., 2001; Dou et al., 2004; Nagabukuro and
Berkley, 2007).
The small increase in the VMR threshold that was produced,
when the vehicle was injected i.p. was not significant, and was
not reproduced after the vehicle was injected s.c. in the neck. This
result indicates that the effect was due to the injection itself, not to
the vehicle. Thus it is important to recognize that injections may
influence the VMR when they are performed close to the recording
site (i.e., the abdomen).
Although tethered VMR-based techniques have been proven to
be a useful tool in pain-related studies (Nagabukuro and Berkley,
2007; Dmitrieva et al., 2010), frequent repairs of the exposed
electrode ends limits its usage in conscious rats to short-term
studies. Psychophysics-based technique is an excellent tool for
assessing pain-related behavior in rats with ENDO (Cason et al.,
2003) but it requires rat pre-screening and training that can
limit its applicability when long-term studies are considered. An
advantage of telemetry-based VMR technique is that rats require
minimal training and are not tethered during the experiment.
Together, our findings indicate that the telemetric technique for
assessing vaginal hyperalgesia in a rat model of ENDO is fea-
sible and applicable for long-term pharmaceutical studies. Our
results also suggest that COX activity plays a role in the vaginal
hyperalgesia induced by ENDO. Because products of COX activity
can trigger pain in different inflammatory conditions, ENDO-
associated pain resembles inflammatory pain. Insofar as findings
in the rat relate to ENDO in women, our findings here are in
line with other evidence that links COX2 to the development and
maintenance of ectopic endometrial growths and together sup-
port the conclusion that ENDO-associated pain has inflammatory
origins.
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